07.30.20

Roche’s Actemra/RoActemra Fails in Severe COVID-19-Associated Pneumonia Study

Source: Roche

05.29.20

Roche’s Actemra/RoActemra Paired With Gilead’s Remdesivir in COVID-19 Pneumonia Study

Source: FirstWord

04.28.20

Sanofi/Regeneron and Roche Report Mixed Results for Potential COVID-19 Treatments

Source: FirstWord

03.23.20

FDA Approves Genentech’s Clinical Trial for Actemra to Treat Hospitalized Patients With Severe COVID-19 Pneumonia

Source: Genentech

03.19.20

Roche Initiates Phase 3 Trial of Actemra/RoActemra in Patients With Severe COVID-19 Pneumonia

Source: Roche

View more stories